ARCHIVES

CAM Therapies Should Be Held to Conventional Standards and Congress Should Toughen Dietary Supplements Act, IOM Panel Says.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

Vasopermeation Technology Awarded Patent For CA Firm.

September 28, 2001

Unclear Whether Clinical Trials Benefit Patients, Review Finds

February 27, 2004

In Brief: NCI Seeking Industry Support Again For Summer Program Congress Oks Smokeless Tobacco Bill

February 14, 1986

Anil Potti Resigns From Duke University

November 19, 2010

Conversation with The Cancer Letter: Scott Soefje: “These are Life-Saving Drugs. I’m Not Going To Stop Treating Patients, Right?”

October 3, 2014

Trimodality Therapy Improves Survival In Early Disease

January 27, 2006